INMB

INmune Bio Inc. is a cutting-edge, clinical-stage immunotherapy firm based in La Jolla, California, dedicated to redefining treatment paradigms through the reprogramming of the innate immune system to address complex diseases, including cancer and Alzheimer’s disease. The company boasts a promising pipeline of innovative therapies aimed at leveraging the body’s natural immune responses, solidifying its role as a leader in the rapidly evolving immunotherapy sector. By focusing on significant unmet medical needs, INmune Bio underscores its commitment to enhancing health outcomes and elevating the quality of life for patients globally, making it a compelling prospect for institutional investors in the biotech space.